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LAY ABSTRACT
Patients with cardiovascular disease are referred to 
cardiac rehabilitation to help them adopt a healthier li-
festyle and achieve a stable psychological status. How-
ever, cardiac rehabilitation programmes are probably 
not suitable for patients of all body mass indexes. Pa-
tients who are classed as obese may experience more 
difficulty in changing their current lifestyle to a heal­
thier one. During cardiac rehabilitation their quality of 
life might not improve as much as in patients of normal 
weight. This study investigated the differences between 
body mass index classes with regard to improvement in 
quality of life. The results showed that, during cardiac 
rehabilitation, obese patients undergo the same impro-
vements as patients of normal weight. Patients who are 
overweight showed a greater improvement in quality of 
life. It does not seem to be necessary to adjust cardiac 
rehabilitation programmes for patients who are obese; 
at least not with respect to improving quality of life.
Objective: To investigate the relation between body 
mass index class and changes in health-related qua-
lity of life in patients participating in cardiac rehabi-
litation.
Design: Prospective cohort study.
Patients: A total of 503 patients with acute coronary 
syndrome.
Methods: Data from the OPTICARE trial were used, 
in which health-related quality of life was measured 
with the MacNew Heart Disease HRQOL Instrument 
at the start, directly after, and 9 months after com-
pletion of cardiac rehabilitation. Patients were clas-
sed as normal weight, overweight, or obese. 
Results: During cardiac rehabilitation, global health-
related quality of life improved in patients in all clas-
ses of body mass index. Patients classed as over-
weight had a significantly greater improvement in 
social participation than those classed as normal 
weight (5.51–6.02 compared with 5.73–5.93, re-
spectively; difference in change 0.30, p = 0.025). Af-
ter completion of cardiac rehabilitation, health-rela-
ted quality of life continued to improve similarly in 
patients in all classes of body mass index.
Conclusion: Health-related quality of life improved 
during cardiac rehabilitation in patients of all classes 
of body mass index. Patients classed as overweight 
showed the greatest improvement. The beneficial 
effects were maintained during extended follow-up 
after completion of cardiac rehabilitation. 
Key words: cardiac rehabilitation; acute coronary syndrome; 
quality of life; body mass index; obesity.
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Since the 1980s cardiac rehabilitation (CR) has been offered to patients with cardiovascular disease 
(CVD) for secondary prevention. A CR programme 
generally encompasses exercise sessions and health 
education. Besides improving physical fitness, adopting 
a healthier lifestyle, and achieving a stable psychological 
status, improving health-related quality of life (HRQOL) 
is one of the main goals of CR (1). Poor HRQOL is asso-
ciated with higher mortality in patients with CVD (2–4). 
HRQOL refers to the impact that health conditions and 
their symptoms have on an individual’s quality of life (5) 
and commonly comprises 3 domains: physical function, 
emotions, and social participation (6, 7).
A recent meta-analysis indicated that HRQOL impro-
ves upon receiving CR (8). However, it is not known 
whether the effects of CR on HRQOL are equally fa-
vourable for patients with and without obesity. Since the 
core of CR consists of weight-bearing exercise sessions, 
which may be challenging for patients with obesity, it 
could be hypothesized that obese patients with CVD 
would not gain the same health benefits as patients of 
normal weight, which might translate into a smaller 
improvement in HRQOL (9). For aerobic capacity, there 
is increasing evidence that effects achieved during CR 
are substantially smaller in patients with obesity compa-
red with patients without obesity, and that these effects 
are non-lasting (10). In addition, obesity is related to a 
higher frequency of psychological problems and proba-
bly to unpleasant feelings when training in a group with 
non-obese peers (11). Thus, we expect smaller gains in 
HRQOL in patients with obesity during CR compared 
with patients of normal weight.
Only a few studies have evaluated the effects of CR 
on HRQOL specifically in obese patients with CVD. 
*This article has been handled and decided upon by Chief-Editor Kristian 
Borg. Henk Stam has not been involved in the decision process.
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A study by Pochmonová et al. showed improvements 
in HRQOL in patients with ischaemic heart disease 
during a 12-week exercise programme, regardless of 
body mass index (BMI) (12). However, the sample size 
in this study was small (n = 88) and HRQOL was not 
evaluated on the longer term. Another study (n = 388) 
showed a lower HRQOL (on the physical domain) 
both before and after CR in patients with extreme 
obesity (BMI >35.0 kg/m2) compared with patients 
with overweight (BMI 25.0–29.99 kg/m2) and those 
with obesity (BMI 30.0–35.0 kg/m2) (13). Lavie & 
Milani showed improvements in HRQOL in patients 
with obesity, although with another BMI threshold for 
obesity (BMI ≥ 27.3 kg/m2 in men and ≥ 27.8 kg/m2 
in women) and measured with a generic questionnaire 
(14). A recent study showed a lower HRQOL at the 
start of CR and smaller gains during CR in patients 
with obesity, although this was not investigated in the 
longer term (15). 
Large-scale studies on the role of BMI in the evolu-
tion of HRQOL over time are needed to investigate 
whether CR should be optimized for specific BMI 
classes, and particularly for patients with obesity. Data 
from the EUROASPIRE III study, showing a high 
prevalence of overweight (46%) and obesity (35%) 
in coronary patients in Europe, highlight this need 
(16). The aim of the present study was to investigate 
the relation between 3 BMI classes and changes in 
HRQOL during and after CR in patients with CVD. 
It is hypothesized that patients with obesity show 
smaller improvements in HRQOL than do patients of 
normal weight. 
METHODS
Patient population
Patients were selected from the database of the OPTICARE 
trial, conducted at Capri Cardiac Rehabilitation, Rotterdam-
The Hague, the Netherlands, from 2010 until 2014 (registered 
on ClinicalTrials.gov, number NCT01395095). This study was 
described in detail elsewhere (17). In short, the OPTICARE 
trial was a randomized controlled trial with a primary aim of 
evaluating the effectiveness of 2 extended CR programmes 
vs standard CR. Patients aged ≥ 18 years who experienced an 
acute coronary syndrome (ACS), defined as “persistent (>20 
min) chest pain suggestive of myocardial ischaemia, which is 
unresponsive to nitroglycerine, and which is accompanied by 
ST-T changes (electrocardiographic evidence) and/or cardiac 
troponin elevations (biochemical evidence), regardless of in-
hospital treatment” were included in the OPTICARE trial. All 
patients were fluent in Dutch. Exclusion criteria were severe 
comorbidities, left ventricle ejection fraction <40%, and psy-
chological or cognitive impairments that may disturb participa-
tion in CR. For the current study only data from patients who 
completed standard CR were used. 
The OPTICARE trial was approved by the medical ethics 
committee of Erasmus MC, University Medical Centre Rot-
terdam, The Netherlands (MEC-2010-391) and all participating 
patients provided written informed consent.
Cardiac rehabilitation
Standard CR was provided according to the Dutch guidelines (18, 
19), and consisted of an 90-min exercise programme 2 times a 
week for 12 weeks under the supervision of a physiotherapist. 
Lifestyle and cardiovascular risk factor education was provided on 
cardiovascular disease risk factors, medical information, dietary 
advice and advice on coping with emotions. If needed, comple-
mentary programmes, such as a smoking cessation programme, 
nutritional counselling, and stress management were offered. 
All components of standard CR were group-based. The exercise 
programme was obligatory, whereas other components of CR 
were offered on indication. Before starting the CR programme, 
each patient underwent an interview to determine his/her indivi-
dual programme and needs. Completion of the programme was 
defined as completion of at least 75% of the exercise programme.
Patient selection
A total of 605 patients from the OPTICARE trial were randomi-
zed to standard CR in the first 12 weeks and were included in 
the present study. To investigate the relation between BMI and 
HRQOL during CR, 102 patients were excluded since they did 
not complete standard CR. Therefore, a total of 503 patients 
were eligible for the current study (Fig. 1). To investigate the 
relation between BMI and HRQOL after completing CR, an 
additional 255 patients who received an experimental aftercare 
programme were excluded, resulting in a subpopulation of 248 
patients available for this part of the analysis. 
Data collection
The following baseline data (start of CR) were used: age, sex, 
height, weight, educational level, marital status, risk factors 
and cardiac medication. By using height and weight, BMI was 
Fig. 1. Flow chart of patient selection. HRQOL: health-related quality 
of life; BMI: body mass index; CR: cardiac rehabilitation. 
 
 
 
 
 
 
 
 
 
 
In analysis 
lnvestigating the relationship between 
BMI and HRQOL after completion of CR 
n=248 
 
In analysis 
lnvestigating the relationship between 
BMI and HRQOL during CR 
n=503 
 
Assessed for eligibility 
Patients randomized to standard CR for first 12 
weeks, included in OPTICARE trial 
n=605 
 
Not included in analysis 
Did not complete standard CR (n=102} 
 
Not included in analysis 
Received an experimental 
aftercare program (n=255) 
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calculated and used to classify patients according to the World 
Health Organization (WHO) guidelines, as: normal weight (BMI 
18.5–24.99 kg/m2), overweight (BMI 25.0–29.99 kg/m2), and 
obese (BMI ≥ 30.0 kg/m2) (20). 
HRQOL was measured at the start of CR (T0), directly after 
completion of CR (T1) and 9 months after completion of CR 
(T2). The Dutch version of the MacNew Heart Disease HRQOL 
Instrument (MacNew) was used to measure HRQOL. This self-
administered disease-specific questionnaire for patients with 
ischaemic heart disease meets the criteria for psychometric pro-
perties of reliability, validity and responsiveness and consists of 
27 items. It measures HRQOL on 3 domains (physical function, 
emotions, and social participation) as well as global HRQOL (6, 
7). The score on each domain ranges from 1 (poor HRQOL) to 
7 (high HRQOL). Questions refer to the last 2 weeks.
Statistical analyses
Baseline data were depicted separately for the 3 BMI classes. 
Normality of continuous variables (BMI and age) was checked 
visually and tested with a Kolmogorov-Smirnov test. BMI was 
not normally distributed and displayed as median and interquar-
tile range. Age was normally distributed and displayed as mean 
(standard deviation; SD). Differences in mean age between BMI 
classes were tested by means of analysis of variance (ANOVA). 
Fisher’s least significant difference was used as a post hoc test 
if ANOVA showed a significant difference between the 3 clas-
ses of BMI at baseline. Categorical variables were displayed as 
numbers and percentages and differences between BMI classes 
were tested by means of linear-by-linear χ2 tests for categorical 
variables (or by Fisher’s exact test if groups contained less than 
5 measurements). 
Two linear mixed-effect models were created to analyse 
the relation between BMI and HRQOL: one to investigate the 
relation between BMI and HRQOL at the start and during CR 
(change between T0 and T1), and one to investigate the same 
relation, but after completion of CR (change between T1 and 
T2). HRQOL was modelled as the dependent variable and 
BMI, age, sex (21) (fixed effects) and time since the start of 
CR (random intercept) as explanatory variables. BMI, as deter-
mined at baseline for each patient, was modelled by 2 dummy 
variables in both models, with BMI 18.5–24.99 kg/m2 being 
the reference category. An interaction term between BMI and 
time was included in both models to study if HRQOL changes 
during and after CR differed between BMI classes. Educational 
level, marital status, work status, cardiovascular risk factors and 
cardiac medication appeared not to be associated with both BMI 
or HRQOL, and were therefore not included in the multivariable 
model. R Statistical software (Version 1.1.463, RStudio Team 
(2016). RStudio: Integrated Development for R. RStudio, Inc., 
Boston, MA, USA, URL http://www.rstudio.com/) was used to 
analyse the data. A p-value < 0.05 was considered statistically 
significant. However, to adjust for the inflation of the type I er-
ror probability, significance was stated at < 0.0167 for assessing 
baseline differences between BMI classes, and at < 0.025 for 
the comparison of the 2 higher BMI classes with the reference 
group in the linear mixed-effect models. 
RESULTS
Baseline characteristics
Both the proportion of patients in each of the 3 classes 
of BMI and baseline values for HRQOL were compa-
rable between patients included and excluded in the 
analysis (results not shown). 
Mean time (95% confidence interval; 95% CI) 
between hospital discharge and admission to CR was 
44.4 (41.5, 47.2) days. Patients classed as overweight 
were the largest group (49.1%), followed by patients 
with obesity (27.4%) and patients of normal weight 
(23.5%). At the start of CR, patients with obesity 
were significantly younger than patients of a normal 
weight (55.8 vs 59.5 years, respectively, p = 0.005, 
Table I). Furthermore, a higher BMI was associated 
with a higher frequency of risk factors: 62.3% of the 
patients with obesity had heart disease in their family 
history (p = 0.004), 20.3% had a diagnosis of diabetes 
(p = 0.001), 44.2% dyslipidaemia (p = 0.007) and 47.1% 
hypertension (p = 0.005) (Table I). 
Relation between BMI class and HRQOL during and 
after cardiac rehabilitation
At the start of CR, no significant differences in HRQOL 
were shown between BMI classes (Table II). 
During CR, mean  HRQOL increased in the total 
study population from 5.11 to 5.63 on physical func-
tion, from 5.13 to 5.41 on emotions, from 5.59 to 5.97 
on social participation, and from 5.24 to 5.63 on global 
HRQOL. Patients classed as overweight had a signi-
ficantly greater improvement in HRQOL compared 
with patients of normal weight in social participation 
(5.51–6.02 compared with 5.73–5.93, p = 0.025) (Table 
II). No differences were found for patients with obesity 
compared with patients of normal weight. 
After completion of CR, HRQOL increased in the 
total study population from 5.61 to 5.89 on physical 
function, from 5.36 to 5.58 on emotions, from 5.90 to 
6.26 on social participation and from 5.60 to 5.83 on glo-
bal HRQOL. Neither patients with overweight or those 
with obesity differed in their improvement in HRQOL 
compared with patients of normal weight (Table III). 
DISCUSSION
To the best of our knowledge, this is the first large 
study investigating the longitudinal relationship bet-
ween BMI and HRQOL in a post-ACS CR population, 
comprising the periods both during and after CR. After 
starting at comparable HRQOL levels, HRQOL impro-
ved during and after completion of CR in all classes 
of BMI. Of note was the larger improvement on one 
domain of HRQOL (social participation) in patients 
classed as overweight compared with patients of nor-
mal weight. This was not observed for patients with 
obesity. There were no differences in improvements 
J Rehabil Med 52, 2020
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in HRQOL between BMI classes between the end of 
CR and 9 months after the end of CR. 
HRQOL values at the start of CR in the current 
study were comparable to those in a study investiga-
ting HRQOL in a large sample of 
Dutch patients with CVD (unk-
nown BMI), entering CR (22). We 
expected that HRQOL would be 
lower in patients with obesity com-
pared with normal weight patients 
at the start of CR, since this was 
found for persons with obesity in 
the general population (23–25). An 
explanation for the absence of this 
difference might be that patients 
in our study have experienced a 
life event, which is likely to affect 
HRQOL in all BMI classes, and 
thereby might have dominated 
the relation between BMI and 
HRQOL. Gunstad et al. found 
a lower HRQOL in CR patients 
with extreme obesity (BMI > 35.0 
kg/m2) compared with patients 
with overweight and patients with 
obesity at the start of CR (13). This 
may suggest that mainly patients 
with extreme obesity might be in 
need of additional care. In OPTI-
CARE, only a very small group 
of 24 patients had a BMI≥35 kg/
m2, and, hence, the current study 
had insufficient power to analyse 
the class of patients with extreme 
obesity to evaluate this suggestion. 
We expected to observe a smal-
ler improvement in HRQOL during 
CR in higher classes of BMI 
compared with lower classes of 
BMI when following an exercise-
based CR programme. However, 
patients classed as overweight 
improved more in HRQOL during 
CR compared with normal weight 
patients, and exceeded the clini-
cally important change of 0.5 
points (26) It cannot be ruled out 
that this larger improvement might 
be a result of a slightly (but not sig-
nificantly) lower level at the start 
of CR in patients with overweight 
(i.e. regression towards the mean). 
In addition, it should be kept in 
mind that the improvement is a 
mean of the change and that the 
lower boundary of the confidence 
interval is below the clinically im-
portant change of 0.5. Therefore, 
Table I. Baseline characteristics for patients of normal weight (body mass index (BMI) 
18.5–24.99 kg/m2), overweight (BMI 25.0–29.99 kg/m2) or obesity (BMI ≥ 30 kg/m2) 
(n = 503)
Characteristics 
Normal weight
(n = 118)
Overweight
(n = 247)
Obese
(n = 138) p-value 
BMI, kg/m2, median (IQR) 23.6 (22.2, 24.5) 27.6 (26.2, 28.7) 32.1 (31.1, 34.1) 
Sex, males, n (%) 89 (75.4) 207 (83.8) 114 (82.6) 0.161
Age, years, mean (SD) 59.5 (9.4) 57.6 (9.2) 55.8 (9.0) 0.0051** 
Educational level, n (%) 0.097
Low 4 (4.0) 10 (5.1) 4 (3.5)
Intermediate 58 (57.4) 124 (63.3) 84 (74.3)
High 39 (38.6) 62 (31.6) 25 (22.1) 
Missing 17 51 25
Marital status, n (%) 0.713
Partnered 84 (82.4) 169 (86.2) 91 (80.5)
Unpartnered 18 (17.6) 27 (13.8) 22 (19.5) 
Missing 16 51 25
Work status, n (%) 0.830
Employed 56 (58.3) 108 (59.3) 59 (56.7)
Unemployed 40 (41.7) 74 (40.7) 45 (43.3) 
Missing 22 65 34
Risk factors, n (%)
Family history 52 (44.1) 130 (52.6) 86 (62.3) 0.004**
Diabetes 7 (5.9) 28 (11.3) 28 (20.3) 0.001**
Dyslipidaemia 32 (27.1) 99 (40.1) 61 (44.2) 0.007**
Hypertension 35 (29.7) 101 (40.9) 65 (47.1) 0.005**
Smoking (pre-ACS) 46 (39.0) 87 (35.2) 60 (43.5) 0.441
Cardiac medication, n (%)
Acetylsalicylic acids 114 (97.4) 241 (97.6) 136 (98.6) 0.853
Thienopyridines 100 (85.5) 197 (79.8) 120 (87.0) 0.677
Statins 115 (98.3) 243 (98.4) 129 (93.5) 0.027*
Beta blockers 92 (78.6) 205 (83.0) 117 (84.8) 0.217
ACE inhibitors 83 (70.9) 116 (67.2) 103 (74.6) 0.494
*p < 0.05, **p < 0.01. 
1Post hoc tests showed a significant difference between normal weight and obese participants (p = 0.001) 
and no significant difference between normal weight and overweight participants (p = 0.061) or between 
overweight and obese participants (p = 0.065). 
ACS: acute coronary syndrome; ACE: angiotensin-converting-enzyme: IQR: interquartile range; SD: 
standard deviation.
Table II. Mean health-related quality of life values per body mass index (BMI) class at 
the start of cardiac rehabilitation (CR) and directly after completion of CR, and mean 
change in HRQOL during CR (n = 503)
BMI classes
At the start of CR 
(T0)
Mean (95% CI) p-value
Directly after 
completion of CR 
(T1) 
Mean (95% CI)
Change during CR
(Δ T0–T1)
Mean (95% CI) p-value
Physical function
  < 25 kg/m2 5.24 (5.01, 5.46) 5.60 (5.38, 5.83) 0.37 (0.14, 0.59)
  25–30 kg/m2 5.08 (4.92, 5.24) 0.258 5.71 (5.54, 5.87) 0.63 (0.47, 0.79) 0.036
  ≥ 30 kg/m2 5.04 (4.83, 5.25) 0.216 5.47 (5.26, 5.69) 0.43 (0.22, 0.65) 0.643
Emotions
  < 25 kg/m2 5.23 (5.01, 5.45) 5.46 (5.24, 5.68) 0.23 (0.01, 0.45)
  25–30 kg/m2 5.08 (4.93, 5.24) 0.289 5.37 (5.21, 5.53) 0.28 (0.12, 0.44) 0.657
  ≥ 30 kg/m2 5.13 (4.92, 5.33) 0.499 5.38 (5.17, 5.59) 0.26 (0.05, 0.46) 0.845
Social participation
  < 25 kg/m2 5.73 (5.51, 5.95) 5.93 (5.71, 6.16) 0.20 (–0.02, 0.43)
  25–30 kg/m2 5.51 (5.36, 5.67) 0.113 6.02 (5.85, 6.18) 0.50 (0.34, 0.67) 0.025*
  ≥ 30 kg/m2 5.62 (5.41, 5.83) 0.463 5.91 (5.70, 6.13) 0.30 (0.08, 0.51) 0.542
Global
  < 25 kg/m2 5.35 (5.15, 5.54) 5.64 (5.44, 5.83) 0.29 (0.09, 0.49)
  25–30 kg/m2 5.19 (5.05, 5.33) 0.206 5.67 (5.52, 5.81) 0.48 (0.33, 0.62) 0.069
  ≥ 30 kg/m2 5.21 (5.03, 5.40) 0.329 5.54 (5.35, 5.73) 0.33 (0.14, 0.52) 0.718
*p < 0.025. 95% CI: 95% confidence interval. Results are based on multivariable linear mixed­effect 
modelling. BMI< 25 is the reference group for all analyses.
www.medicaljournals.se/jrm
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we cannot rule out that this finding might be due to 
chance. We do not have another explanation for these 
unexpected findings, but future studies on the relation-
ship between BMI and changes in physical activity, 
physical fitness, and psychological factors should be 
performed to confirm this relationship and, if true, 
may add to elucidation of the underlying mechanisms.
The patients with obesity in the current study im-
proved in HRQOL during CR in a comparable manner 
to that of normal weight patients, but did not exceed 
the clinically important change of 0.5 points (26). 
It seems that patients with obesity will, on average, 
improve close to, or slightly exceeding, the 0.5-point 
limit during the 9 months after completion of CR 
compared with baseline levels. It should be noted that 
it cannot be excluded that the current results are valid 
only for a subgroup patients with obesity who are 
highly motivated, since they consented to participate 
in a trial designed to investigate the effects of extended 
CR programmes. Considering this, one could question 
the generalizability of the present results to the entire 
CVD population with obesity participating in CR. 
Consequently, it is recommended to further investi-
gate changes in HRQOL in this population, including 
patients with extreme obesity (BMI ≥ 35 kg/m2). 
Limitations
This study has some limitations. First of all, approx-
imately 20% of the patients did not complete standard 
CR and were excluded from analysis. However, drop-
out of CR was equally distributed among BMI classes 
and is therefore not expected to have influenced our 
conclusions. Secondly, it was not possible to conclude 
whether the improvements 
found in HRQOL were due 
to the CR programme, since, 
due to ethical considerations, a 
control group not participating 
in CR was unavailable. 
The results of the current 
study suggest that, from a 
HRQOL perspective, it does 
not seem necessary to adjust 
the standard rehabilitation 
programme for patients with 
overweight and those with 
obesity. However, besides 
HRQOL, CR is also focused 
on increasing physical activity, 
physical fitness and restoring 
psychological wellbeing. To in-
form CR centres, these aspects 
need to be investigated in their 
relationship with BMI, since 
they are at least as important as HRQOL with regard 
to secondary prevention.
Conclusion
Normal weight, overweight and obese patients with 
CVD started CR at comparable HRQOL levels. Im-
provements in HRQOL were seen for all classes of 
BMI. Patients of normal weight and those with obesity 
improved equally in HRQOL during CR, whereas 
patients with overweight improved more. Further 
research is needed with respect to other CR goals, 
such as improving physical activity, physical fitness 
and psychological status, and the differences in effects 
between classes of BMI requires attention, especially 
as there is a large and increasing population of patients 
with CVD and obesity. 
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  <25 kg/m2 5.38 (5.06, 5.69) 5.41 (5.08, 5.75) 0.04 (–0.30, 0.37)
  25–30 kg/m2 5.35 (5.14, 5.57) 5.68 (5.45, 5.91) 0.33 (0.10, 0.55) 0.180
  ≥30 kg/m2 5.30 (5.03, 5.57) 5.44 (5.14, 5.74) 0.14 (–0.16, 0.44) 0.672
Social participation
  <25 kg/m2 5.79 (5.49, 6.09) 6.14 (5.81, 6.47) 0.35 (0.02, 0.68)
  25–30 kg/m2 6.01 (5.80, 6.22) 6.41 (6.19, 6.63) 0.40 (0.18, 0.62) 0.821
  ≥30 kg/m2 5.79 (5.53, 6.06) 6.06 (5.77, 6.35) 0.27 (–0.03, 0.56) 0.732
Global
  <25 kg/m2 5.55 (5.28, 5.83) 5.74 (5.45, 6.03) 0.19 (–0.11, 0.48)
  25–30 kg/m2 5.71 (5.52, 5.90) 5.98 (5.78, 6.18) 0.27 (0.07, 0.47) 0.628
  ≥30 kg/m2 5.44 (5.20, 5.68) 5.61 (5.35, 5.87) 0.17 (–0.09, 0.43) 0.944
CI: confidence interval. Results are based on multivariable linear mixed­effect modelling. BMI<25 is the 
reference group for all analyses.
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